Hypoglycemia is common and dangerous in diabetes mellitus, so identifying at-risk patients may lead to useful preventive strategies. This Regenstrief-Merck partnership aims to design a risk calculator to aid clinicians in identifying at-risk patients who may benefit from preventive strategies. The project team members will conduct a retrospective cohort analysis, focus-group discussions, use of a new computer-based risk-prediction tool, and assessment of processes and outcomes associated with usage of the tool among healthcare providers.
In The NewsView All
Regenstrief Research Scientist Alexia M. Torke, M.D., M.S., described how chaplain support care for family members in charge of making tough decisions for their loved ones in the ICU can help improve their overall mental health.Read More
‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia
Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many...Read More
Featured FellowshipView all
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
NewsFactors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research
NewsMulti-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance